Filing Details

Accession Number:
0001104659-12-050217
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-20 19:21:04
Reporting Period:
2012-07-18
Filing Date:
2012-07-20
Accepted Time:
2012-07-20 19:21:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1475990 L John Slebir 1172 Castro Street
Mountain View CA 94040
Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-18 6,250 $6.39 10,376 No 4 M Direct
Common Stock Disposition 2012-07-18 6,250 $30.36 4,126 No 4 S Direct
Common Stock Acquisiton 2012-07-18 3,750 $8.74 7,876 No 4 M Direct
Common Stock Disposition 2012-07-18 3,750 $30.36 4,126 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2012-07-18 6,250 $0.00 6,250 $6.39
Common Stock Incentive Stock Option (right to buy) Disposition 2012-07-18 3,750 $0.00 3,750 $8.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,750 2019-09-04 No 4 M Direct
30,916 2021-01-21 No 4 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2012.
  2. Includes 1,993 shares acquired under the VIVUS, Inc. Employee Stock Purchase Plan on May 14, 2012.
  3. Twenty-five percent (25%) of the total number of shares became exercisable on 9/4/2010 and one forty-eighth (1/48th) of the total number of shares become exercisable at the end of each full month thereafter until the option is fully vested on 9/14/2013.
  4. Twenty-five percent (25%) of the total number of shares became exercisable on 1/21/2012 and one forty-eighth (1/48th) of the total number of shares become exercisable at the end of each full month thereafter until the option is fully vested on 1/21/2015.